Kalos, Michael
Next Pillar Consulting,
United States
2024 Rank: 71378
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2016 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71378 | 74052 |
| Total Cites | 18419 | 20138 |
| H-index | 46 | 50 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 102 | 126 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2441 | 2624 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 3367 | 3638 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12235 | 12905 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.56 |
| Self-Citation Percentage |
8.54%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2023 Rank: 69971
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2010 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69971 | 72430 |
| Total Cites | 16858 | 18519 |
| H-index | 45 | 49 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 100 | 124 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2300 | 2481 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 3095 | 3360 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11075 | 11712 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.58 |
| Self-Citation Percentage |
8.97%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2022 Rank: 69991
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2061 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69991 | 73100 |
| Total Cites | 14705 | 16281 |
| H-index | 43 | 46 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 95 | 119 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 2104 | 2278 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 2777 | 3029 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9470 | 10048 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.62 |
| Self-Citation Percentage |
9.68%
|
|
Kalos, Michael
Eli Lilly and Company,
United States
2021 Rank: 68529
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2018 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68529 | 71429 |
| Total Cites | 13776 | 15299 |
| H-index | 43 | 46 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 92 | 115 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 2010 | 2179 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 2627 | 2870 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8808 | 9359 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.63 |
| Self-Citation Percentage |
9.95%
|
|
Kalos, Michael
Arsenal Biosciences,
United States
2020 Rank: 70760
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2055 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70760 | 70967 |
| Total Cites | 11410 | 12814 |
| H-index | 40 | 45 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 85 | 108 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 1773 | 1937 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 2229 | 2457 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7154 | 7648 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.68 |
| Self-Citation Percentage |
10.96%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.